| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NB100-65424-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP1-43126-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-73398 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP1-43393-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-00462-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-73148 | |||
![Flow Cytometry: ICOS Antibody (ISA-3) [NBP1-43126] - Staining of CD3 + CD28 stimulated human PBMC with Anti-Human CD278 (ICOS) FITC (left), and Anti-Human CD278 (ICOS) PE (right). Appropriate isotype controls were used (open histogram). Total viable cells were used for analysis](http://images.novusbio.com/fullsize/ICOS-Antibody-ISA-3-Flow-Cytometry-NBP1-43126-img0001.jpg "Flow Cytometry: ICOS Antibody (ISA-3) [NBP1-43126] - Staining of CD3 + CD28 stimulated human PBMC with Anti-Human CD278 (ICOS) FITC (left), and Anti-Human CD278 (ICOS) PE (right). Appropriate isotype controls were used (open histogram). Total viable cells were used for analysis")
![Western Blot: PIAS2 Antibody (2B5) [NBP2-46394] - Analysis of HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY PIAS2.](http://images.novusbio.com/fullsize/PIAS2-Antibody-2B5-Western-Blot-NBP2-46394-img0001.jpg "Western Blot: PIAS2 Antibody (2B5) [NBP2-46394] - Analysis of HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY PIAS2.")
![Flow Cytometry: E-selectin Antibody (P2H3) [NBP1-43393] - Staining of TNF alpha-stimulated Human Umbilical Vein Endothelial Cells (HUVEC) with 0.5 ug of Mouse IgG1 kappa Isotype Control Purified (open histogram) or 0.5 ug of Anti-Human CD62E (E- Selectin) Purified (filled histogram) followed by F(ab')2 Anti-Mouse IgG PE . Total viable cells were used for analysis.](http://images.novusbio.com/fullsize/E-selectin-Antibody-P2H3-Flow-Cytometry-NBP1-43393-img0001.jpg "Flow Cytometry: E-selectin Antibody (P2H3) [NBP1-43393] - Staining of TNF alpha-stimulated Human Umbilical Vein Endothelial Cells (HUVEC) with 0.5 ug of Mouse IgG1 kappa Isotype Control Purified (open histogram) or 0.5 ug of Anti-Human CD62E (E- Selectin) Purified (filled histogram) followed by F(ab')2 Anti-Mouse IgG PE . Total viable cells were used for analysis.")
![Flow Cytometry: MHC Class II Antibody (HIS19) [NBP2-00462] - Analysis using the FITC conjugate of NBP2-00462. Staining of rat splenocytes with Anti-Rat MHC Class II FITC (left) and PE (right). Appropriate isotype controls were used (open histogram). Total viable cells were used for analysis.](http://images.novusbio.com/fullsize/MHC-Class-II-Antibody-HIS19-Flow-Cytometry-NBP2-00462-img0002.jpg "Flow Cytometry: MHC Class II Antibody (HIS19) [NBP2-00462] - Analysis using the FITC conjugate of NBP2-00462. Staining of rat splenocytes with Anti-Rat MHC Class II FITC (left) and PE (right). Appropriate isotype controls were used (open histogram). Total viable cells were used for analysis.")
![Western Blot: Orai2 Antibody (8D11) [NBP2-46295] - Analysis of HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY ORAI2.](http://images.novusbio.com/fullsize/Orai2-Antibody-8D11-Western-Blot-NBP2-46295-img0001.jpg "Western Blot: Orai2 Antibody (8D11) [NBP2-46295] - Analysis of HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY ORAI2.")
![Western Blot: IA-2/PTPRN Antibody [NBP1-00134] - Analysis of PTPRN in NIH 3T3 lysate (35ug protein in RIPA buffer) using this antibody at 0.5 ug/ml. Primary incubation was 1 hour. Detected by chemiluminescence.](http://images.novusbio.com/fullsize/IA-2-PTPRN-Antibody-Western-Blot-NBP1-00134-img0003.jpg "Western Blot: IA-2/PTPRN Antibody [NBP1-00134] - Analysis of PTPRN in NIH 3T3 lysate (35ug protein in RIPA buffer) using this antibody at 0.5 ug/ml. Primary incubation was 1 hour. Detected by chemiluminescence.")
![Western Blot: CILP-1 Antibody [NB100-41106] - (0.03ug/ml) staining of rat spinal cord lysate (35ug protein in RIPA buffer). Primary incubation was 1 hour. Detected by chemiluminescence.](http://images.novusbio.com/fullsize/CILP-1-Antibody-Western-Blot-NB100-41106-img0004.jpg "Western Blot: CILP-1 Antibody [NB100-41106] - (0.03ug/ml) staining of rat spinal cord lysate (35ug protein in RIPA buffer). Primary incubation was 1 hour. Detected by chemiluminescence.")
![Western Blot: Cyclophilin 40 Antibody [NB100-61665] - Staining of Human Brain (Frontal Cortex) lysate (35 ug protein in RIPA buffer). Antibody at 0.1 ug/mL. Detected by chemiluminescence.](http://images.novusbio.com/fullsize/Cyclophilin-40-Antibody-Western-Blot-NB100-61665-img0001.jpg "Western Blot: Cyclophilin 40 Antibody [NB100-61665] - Staining of Human Brain (Frontal Cortex) lysate (35 ug protein in RIPA buffer). Antibody at 0.1 ug/mL. Detected by chemiluminescence.")
![Western Blot: Bradykinin RB1/BDKRB1 Antibody [NB100-96919] - Analysis of BDKRB1 using NB100-96919 at 2ug/ml in K562 lysate (35ug protein in RIPA buffer). Primary incubation was 1 hour. Detected by chemiluminescence.](http://images.novusbio.com/fullsize/Bradykinin-RB1-BDKRB1-Antibody-Western-Blot-NB100-96919-img0003.jpg "Western Blot: Bradykinin RB1/BDKRB1 Antibody [NB100-96919] - Analysis of BDKRB1 using NB100-96919 at 2ug/ml in K562 lysate (35ug protein in RIPA buffer). Primary incubation was 1 hour. Detected by chemiluminescence.")
![Western Blot: Siglec-6/CD327 Antibody [NBP1-49856] - (0.5ug/ml) staining of Human Placenta lysate (35ug protein in RIPA buffer). Primary incubation was 1 hour. Detected by chemiluminescence.](http://images.novusbio.com/fullsize/Siglec-6-CD327-Antibody-Western-Blot-NBP1-49856-img0003.jpg "Western Blot: Siglec-6/CD327 Antibody [NBP1-49856] - (0.5ug/ml) staining of Human Placenta lysate (35ug protein in RIPA buffer). Primary incubation was 1 hour. Detected by chemiluminescence.")
![Immunocytochemistry/Immunofluorescence: ALMS1 Antibody [NB100-1195] - Immunofluorescence analysis of paraformaldehyde fixed HepG2 cells, permeabilized with 0.15% Triton. Primary incubation 1hr (10 ug/mL) followed by Alexa Fluor 488 secondary antibody (2 ug/mL), showing cytoplasmic staining. The nuclear stain is DAPI (blue). Negative control: Unimmunized goat IgG (10ug/ml) followed by Alexa Fluor 488 secondary antibody (2 ug/mL).](http://images.novusbio.com/fullsize/ALMS1-Antibody-Immunocytochemistry-Immunofluorescence-NB100-1195-img0002.jpg "Immunocytochemistry/Immunofluorescence: ALMS1 Antibody [NB100-1195] - Immunofluorescence analysis of paraformaldehyde fixed HepG2 cells, permeabilized with 0.15% Triton. Primary incubation 1hr (10 ug/mL) followed by Alexa Fluor 488 secondary antibody (2 ug/mL), showing cytoplasmic staining. The nuclear stain is DAPI (blue). Negative control: Unimmunized goat IgG (10ug/ml) followed by Alexa Fluor 488 secondary antibody (2 ug/mL).")
![Immunocytochemistry/Immunofluorescence: ALMS1 Antibody [NB100-1195] - Immunofluorescence analysis of paraformaldehyde fixed HeLa cells, permeabilized with 0.15% Triton. Primary incubation 1hr (10 ug/mL) followed by Alexa Fluor 488 secondary antibody (2 ug/mL), showing cytoplasmic staining. The nuclear stain is DAPI (blue). Negative control: Unimmunized goat IgG (10 ug/mL) followed by Alexa Fluor 488 secondary antibody (2 ug/mL).](http://images.novusbio.com/fullsize/ALMS1-Antibody-Immunocytochemistry-Immunofluorescence-NB100-1195-img0001.jpg)